Cancel
Nutcracker Therapeutics
See Linkedin
Nutcracker Therapeutics Employees
8 people indexed:
-
yvw85w.0ivdd3@wfhq0hhijj2.j60 Sign up to see email
-
Benjamin Eldridge
Co-founder and Chief Technology Officer
-
Chuck Sholtz
Vice President, Intellectual Property
jbpbf.349y2q@3y2gpqj14fd.wg7 Sign up to see emaily0yw8.55i4i2@143wvi1d0p1.pp6 Sign up to see email -
Guna Kannan
Senior Vice President, Protein Engineering
f15j.wfzpfh@5246wpsfq8v.42d Sign up to see email2fzi.qi2sd2@3ljs204y25f.ysq Sign up to see email -
Ian Wiener
Executive Vice President, General Counsel
4bh.qg5y6j@9bdl3y72z1s.8l8 Sign up to see emailz7j.45yl66@8s4fsbb696j.2qs Sign up to see email -
Igor Khandros
Co-founder and Chief Executive Officer
z1y1.zf5fpbqw@3q1f34465v5.0v8 Sign up to see email9237.f38vbzwj@2zqvlp21wl3.yyl Sign up to see email -
wipp.q977zlyw63d@i160vw8l8q6.dy9 Sign up to see email
-
Samuel Deutsch
Chief Scientific Officer
Nutcracker Therapeutics Company Information
Nutcracker Therapeutics, headquartered in Emeryville, California, is at the forefront of RNA therapeutic development. The company has developed a comprehensive RNA platform that integrates advanced engineering with high-precision biosynthesis to enhance the speed, scalability, and safety of RNA therapeutics production. Utilizing proprietary biochips and microfluidic technology in its Nutcracker Manufacturing Unit (NMU), the company ensures quality and consistency through an in-process biochip monitoring system. Nutcracker Therapeutics also offers Nutshell delivery vehicles, which employ peptoids for effective RNA therapeutic delivery. With a focus on a wide range of diseases, including HPV-driven tumors and T cell lymphoma, the company is actively developing a pipeline of RNA therapeutics. Additionally, their CodonCrackerSM software optimizes RNA sequences for better protein expression and manufacturability, supporting their GMP-in-a-box approach to streamline RNA manufacturing. Nutcracker Therapeutics aims to expedite the delivery of RNA therapeutics to patients by forming strategic partnerships and collaborations.
Report inaccurate information
Report inaccurate information